Unidad de Desarrollo e Investigación en Bioterapéuticos (UDIBI), Mexico
Executive Director
Dr. Perez Tapia is a Full Research Professor at the National School of Biological Sciences (ENCB) of the National Polytechnic Institute (IPN) and a Lecturer at the National Autonomous University of Mexico (UNAM). She specializes in the innovation and regulatory affairs of biologics and biotechnological products.
Dr. Perez Tapia has published 114 articles, seven book chapters, and directed over 60 theses. She holds a patent in 39 countries and has nine ongoing patent submissions. Recognized by Forbes as one of Mexico’s most influential women in 2020 and 2021, she is a member of the National System of Researchers (SNI, Level 2) and Research Professor (Level 9).
As the Director of the Unit for Development and Research in Biotherapeutics (UDIBI) at UDIMEB-IPN, she led the development of Mexico’s first diagnostic kit for anti-SARS-CoV2 antibodies. Dr. Perez Tapia serves on the Committee of Biotechnological Products of the Mexican Pharmacopoeia (FEUM) and participates in several CONAHCYT-supported projects.
Register for the Biosimilars LatAm – Europe 2024